UNSPSC 51283705: Cefminox

This classification denotes a cephalosporin antibiotic with the molecular formula C16H21N7O7S3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier PW08Y13465, chemically known as 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((((2s)-2-amino-2-carboxyethyl)thio)acetyl)amino)-7-methoxy-3-(((1-methyl-1h-tetrazol-5-yl)thio)methyl)-8-oxo-, (6r,7s)- but generally known as cefminox, which bears US NIH Compound Identifier 71141.

UNSPSC 51283705 Cefminox is a Commodity code that classifies specific pharmaceutical products, but the recent state and local opportunities tagged to it diverge significantly from the code's nominal scope. The Illinois Department of Public Health's August 2026 piggyback award through MMCAP Infuse to Chartwell Rx LLC supplied Doxycycline Hyclate 100mg tablets and Ciprofloxacin Hydrochloride 500mg tablets—broad-spectrum antibiotics, not cefminox specifically. Seminole County, Florida's June 2026 IFB solicited Naloxone and Safe Drug Deactivation Systems for community health and overdose response, a public-health commodity unrelated to cephalosporin antibiotics. The code shows little relevant recent activity aligned with its stated pharmaceutical classification. State and local procurement of pharmaceuticals under this code does not appear to be driving current solicitation volume in either case.

The two recent opportunities span different issuing bodies and geographies. Illinois Department of Public Health used a cooperative purchasing mechanism (MMCAP Infuse piggyback), while Seminole County, Florida conducted a standalone competitive IFB. The Illinois award valued $2,999,999.11 over three years with an initial 12-month term; the Seminole County solicitation required 1,900 units of Naloxone and 800 deactivation systems annually with quarterly deliveries, initial two-year term and one-year renewal option. Neither opportunity demonstrates a clear state and local procurement pattern tied to cefminox as a product line. The mismatch between the code's classification and the actual goods being procured suggests either miscoding at the point of solicitation or limited current demand for the specific pharmaceutical under this taxonomy.